Plasmodium, the parasite responsible for malaria, impairs the ability of key cells of the immune system to trigger an efficient immune response. This might explain why patients with malaria are susceptible to a wide range of other infections and fail to respond to several vaccines. In a study published today in the open access journal Journal of Biology (http://jbiol.com/), researchers show that if dendritic cells, the key cells involved in initiating immunity, are exposed to red blood cells infected with Plasmodium chabaudi, they initiate a sequence of events that result in compromised antibody responses. The researchers show that this is due to the presence of hemozoin, a by-product of the digestion of hemoglobin by Plasmodium, in infected red blood cells. These observations also explain why vaccines for many diseases are so ineffective during malaria infection, and suggest that the use of preventive anti-malarial drugs before vaccination may improve vaccine-induced protection.
In a study funded by the Wellcome Trust, Owain Millington and colleagues from the University of Strathclyde, UK, studied the effects of Plasmodium chabaudi, the mouse Plasmodium, on mice antigen-presenting dendritic cells in culture and confirmed their findings in live mice.
Millington et al.'s results show that dendritic cells exposed to P. chabaudiinfected red blood cells do not activate normally. They express lower levels of membrane molecules that stimulate other cells of the immune system, and their cytokine production is lower than that of normal dendritic cells. Millington et al. demonstrate that this is caused by exposure to hemozoin present in infected red blood cells.
Millington et al. then show that P.chabaudi-infected dendritic cells fail to activate helper T cells properly T cells are activated but show reduced proliferation and cytokine production in culture. Importantly, during malaria infection, T cells fail to migrate to B-cell areas of lymph nodes Page: 1 2 Related biology news :1
Contact: Juliette Savin
. Malaria -- Effective insecticide-repellent synergy against mosquito vectors2
. Malaria-resistant mosquitoes battle disease with molecular warhead3
. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa4
. Malaria in pregnancy: What can the social sciences contribute?5
. Malaria: The right vaccine in the right place?6
. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine7
. 20 Years of Malaria Research: Outcomes and Perspectives8
. Malaria poses additional risks for first-time mothers9
. Malaria drug may treat metabolic syndromes many symptoms10
. Malaria: Efficacy of monotherapies in Cameroon11
. Malaria, potato famine pathogen share surprising trait